ImaginePharma
  • Pipeline
  • Platforms
    • Programs
    • Oral Delivery
    • Therapeutics
    • Regenerative Medicine
    • Programs
    • PT-1 EPO
    • PT-2 Octreotide
    • PT-3 GLP-1 Agonist
    • Programs
    • Top-1 Skin Graft
    • Top-2 Diabetic Wound
    • Top-3 Burns
    • Programs
    • AIPC
    • T1 Diabetes Autologous Transplant
  • Islet Services
  • News & Resources
  • About Us
    • Programs
    • Leadership
  • Contact Us

Imagine Pharma
Resources & News

Presentation

APICs: A Viable Cellular Treatment for Diabetes

Download
News

Imagine Pharma Builds New State-of-the Art Laboratory in Pittsburgh Economic Opportunity Zone

Read More
Poster

IMG-1 Normalizes Blood Glucose Levels by Inhibiting Glucagon Levels in ZDF Rats

Download
Poster

IMG-1 Reduces Blood Glucose Levels in Rat and Mouse STZ Models

Download
Poster

IMG-1 Lowers Insulin Resistance by Decreasing Hepatic Glucose Production in a DIO Mouse Clamp Test

Download
  • Programs
    • PT-1 EPO
      • PT-2 Octreotide
      • PT-3 GLP-1 Agonist
    • Top-1 Skin Graft (Donor)
      • Top-2 Diabetic Wound
      • Top-3 Burns (2nd Degree)
    • AIPC
      • T1 Diabetes Autologous Transplant
  • Platforms
    • Oral Delivery
    • Therapeutics
    • Regenerative Medicine
  • Islet Services
  • News
  • About Us
    • Leadership
    • Careers
    • Contact Us
ImaginePharma

© Imagine Pharma, Inc. 2025 | Privacy Policy

  • Follow us
  • LinkedIn